# A Study to Test Different Doses of BI 456906 in Patients With Obesity

> **NCT03591718** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 131 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** BI 456906
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03591718
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-04-30
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03591718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03591718, "A Study to Test Different Doses of BI 456906 in Patients With Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03591718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*